Intelligence · Clinical Pipeline
Phase I Pipeline Programs
First-in-human and early clinical safety studies in Phase I.
- Programs
- 4,713
Quick answer
NovaPharmaNews tracks 4,713 phase i pharmaceutical pipeline programs from ClinicalTrials.gov. First-in-human and early clinical safety studies in Phase I.
Top sponsors
- BRIGHT MINDS BIOSCIENCES 327 programs
- Takeda 276 programs
- Anaxis Pharma 204 programs
- Chinese Academy of 190 programs
- United Therapeutics Europe 184 programs
- Teva Pharma 154 programs
- First People's Hospital 149 programs
- Regeneron UK 126 programs
- Boehringer Ingelheim 94 programs
- Sunshine Guojian Pharmaceutical 85 programs
- Lakefront Biotherapeutics NV 62 programs
- HOFFMANN-LA ROCHE 58 programs
-
Losartan potassium 50mg
United Therapeutics Europe Ltd
Emotional Processing
1 trial -
Losartan potassium/Hydrochlorothiazide
Teva Pharma GmbH
Healthy
2 trials -
Losmapimod 15 mg oral tablet
Fulcrum Therapeutics
Healthy Adult Subjects
1 trial -
Low Density Lipoprotein Receptor mRNA Exosomes
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Familial Hypercholesterolemia
1 trial -
Low Dose MSH2-/- tumor cell vaccine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
pMMR/MSS Advanced Colorectal Cancer
1 trial -
Low Dose REN001
OnKure Therapeutics
Fatty Acid Oxidation Disorders
1 trial -
Low Level Laser Therapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Orthodontic Appliance Complication
1 trial -
Low dose ET019002- T Cells
The First People's Hospital of Lianyungang
B-Cell Malignancies
1 trial -
Low-dose RSV mRNA vaccine
Sinovac Research and Development Co.,
RSV
1 trial -
Lu AF28996
H. Lundbeck A/S
Parkinson Disease
1 trial -
Lu AF28996 in Patients With Parkinson's Disease
H. Lundbeck A/S
Parkinson's Disease
1 trial -
Lubiprostone
Takeda
Chronic Constipation, Methanogenesis
1 trial -
Lubiprostone
Takeda
Other Constipation
1 trial -
Lucid-21-302
Quantum Biopharma
Heathy Participants
1 trial -
Lucid-21-302
Quantum Biopharma
Healthy Participants
1 trial -
Lumason Contrast-Enhanced Ultrasound
United Therapeutics Europe Ltd
Kidney Transplantation
1 trial -
Lumason® contrast agent
United Therapeutics Europe Ltd
Mitochondrial Myopathies
1 trial -
Lurbinectedin
Jazz Pharmaceuticals Ireland Limited
Extensive Stage Lung Small Cell Carcinoma
1 trial -
Lynparza 100 mg film-coated tablets, AZD2281, AZD2281, AZD2281
AstraZeneca AB
solid tumors
1 trial -
Lysogenic HSV virus.
Xiyuan Hospital of China Academy of Chinese Medical Sciences
HNSCC
1 trial -
M1774 (oral ATR inhibitor) in Combination with PLX038 (Topo1 inhibitor) with dose expansion cohorts in patients with advanced solid tumors
The George Institute
Patients with pretreated, metastatic or locally advanced cancer for the dose escalation part and dose expansion cohorts in patients with advanced triple-negative breast cancers and advanced cancers with ATM mutation.
1 trial -
M9466 Alone or in Combination in Advanced Solid Tumors (DDRiver 501)
Merck Sharp and Dohme
Advanced solid tumors
1 trial -
M9466 in Combination with Topoisomerase 1 Inhibitors-based Regimens in Advanced Solid Tumors and Colorectal Cancer (DDRiver 511)
Merck Sharp and Dohme
Advanced solid tumors and colorectal cancer
1 trial -
MARVEL algorithm
Rhythm Pharmaceuticals Netherlands B.V.
Atrioventricular Conduction Block
1 trial -
MB02-SP
Mabxience Research SL
Healthy Volunteers
1 trial -
MBG453
Novartis Pharmaceuticals
Myelodysplastic Syndromes
1 trial -
MBX 1416 (Part A)
MBX Biosciences
Postbariatric Hypoglycemia
1 trial -
MBX 2109
MBX Biosciences
Renal Impairment
1 trial -
MBX 2109 (Part A)
MBX Biosciences
Healthy
1 trial -
MBX 4291
MBX Biosciences
Obesity
1 trial -
MC-1-50
Chongqing Precision Biotech Co., Ltd
Acute Lymphoblastic Leukemia, in Relapse
1 trial -
MC-1-50
Chongqing Precision Biotech Co., Ltd
Systemic Lupus Erythematosus (SLE)
1 trial -
MC-1-50
Chongqing Precision Biotech Co., Ltd
B Cell Lymphoma
1 trial -
MCA-derived MSC therapy in renal transplant recipients
Disc Medicine
Rejection transplanted kidney, BPAR
1 trial -
MCAM
BRIGHT MINDS BIOSCIENCES INC.
Opioid Use Disorder
1 trial -
MCI-186
Tanabe Pharma
Renal Impairment
1 trial -
MDGN-002
Avalo Therapeutics
Crohn Disease
1 trial -
MDMA
BRIGHT MINDS BIOSCIENCES INC.
MDMA ('Ecstasy')
1 trial -
MDMA
BRIGHT MINDS BIOSCIENCES INC.
Metabolism
1 trial -
MEDI1341
Takeda
Parkinson's Disease
2 trials -
METRONIDAZOLE, MOLGRAMOSTIM, Saline Solution Basi 9 mg/ml solution for infusion, FOSFOMYCIN
Lacuna Pharma Pty Ltd
peritonitis
1 trial -
MGD020
United Therapeutics Europe Ltd
HIV (Human Immunodeficiency Virus)
1 trial -
MGL-3196
Madrigal Pharmaceuticals EU Limited
Hepatic Impairment
1 trial -
MGL-3196
Madrigal Pharmaceuticals EU Limited
Healthy
3 trials -
MGL-3196 Tablet
Madrigal Pharmaceuticals EU Limited
Healthy
1 trial -
MIRROR; Multispectral and bimodal fluorescent guided surgery (FGS) of high-grade glioma for refining margin assessment: A phase 1 dose finding study using Cetuximab-IRDye800CW- combined with 5-ALA
Disc Medicine
Glioblastoma
1 trial -
MK-2420 SAD Study
Merck Sharp and Dohme
Rheumatoid arthritis
1 trial -
MK-4318 CIDF Target Engagement Study
Merck Sharp and Dohme
Pain
1 trial
Frequently asked questions
How many Phase I pipeline programs are in the directory?
4,713 published programs match this development stage in our ClinicalTrials.gov index.
What defines this pipeline stage?
Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.
Data attribution: Data sources · All pipeline programs